This study shows that
cancer cells process sugar differently from the rest of the cells in our body.
Not exact matches
CAR - T approaches involve reengineering T -
cells to find and destroy
cancer cells, but that
process can cause cytokine release syndrome (CRS), a life - threatening immune response NantKwest hopes to sidestep.
As a
cancer researcher, do you think the mechanisms of tumor growth are somehow changing to come into line with your perceptions, or is it possible that the
process of our learning more about DNA mutations and
cell architecture and nutrient exchange and epigenetic effects make it possible for us to inch ever closer to understanding that which is already going on under our noses?
Cell replication allows our bodies to grow and develop, yet can result in
cancer when natural
processes misfire.
Processed sugars can be very damaging to the immune system and can even feed
cancer cells.
Free radicals oxidize and damage our body
cells, as a main
process causing aging and
cancers.
It is completely different in the most important ways, which is it does NOT feed
cancer cells in the way highly
processed white sugar does and it does NOT cause chemical reactions in the brain (exactly like heroin)-- keeping you craving more sugary foods / drinks like highly
processed white sugar does.
The body wears out, mutations accumulate faster than can be repaired just through the natural
process of
cell division,
cancer grows, arthritis wracks the world worn joints, the child born with tetralogy of Fallot away from surgical care dies.
Cancer cells travel around the body and begin to attack healthy tissue in a
process called metastasis.
Carcinogens may cause
cancer by altering cellular metabolism or damaging DNA directly in
cells, which interferes with normal biological
processes.
Joe W. Ramos, PhD, deputy director of the UH
Cancer Center and collaborators focused on investigating how these oncogenes and related signals lead to dysregulation of normal processes within the cell and activate highly mobile and invasive cancer cell beh
Cancer Center and collaborators focused on investigating how these oncogenes and related signals lead to dysregulation of normal
processes within the
cell and activate highly mobile and invasive
cancer cell beh
cancer cell behavior.
«Used in
cancer therapy, this
process could increase the impact of a treatment by heating the
cancer cells while introducing the drug compound into the tumor.»
They're also used as biological probes to image
cancer and to study
processes inside
cells,» Pentelute says.
Cancer stem
cells can reproduce themselves through a
process called self - renewal and sustain the growth of a tumor.
Furthermore, it has been shown that the body's natural
process of healing the wound created by surgery can actually spur these residual
cancer cells to metastasize to distant parts of the body and form new growths.
Over the past 15 years, the GFP gene has enabled scientists to watch a plethora of previously murky biological
processes in action: how nerve
cells develop in the brain, how insulin - producing beta
cells form in the pancreas of an embryo, how proteins are transported within
cells, and how
cancer cells metastasize through the body.
The findings by a team of Massachusetts General Hospital (MGH) investigators, which will be published in the April 24 issue of
Cell and are receiving advance online release, support the importance of epigenetics —
processes controlling whether or not genes are expressed — in
cancer pathology and identify molecular circuits that may be targeted by new therapeutic approaches.
The Salford team set out to assess the bioenergetics of
cancer stem
cells — the
processes which allow the
cells to live and thrive — with a view to disrupting their metabolism.
Metastasis, the
process that allows some
cancer cells to break off from their tumor of origin and take root in a different tissue, is the most common reason people die from
cancer.
But Whitehead Institute researchers have found a mechanism underlying this resistance — a mechanism that naturally occurs in many diverse
cancer types and that may expose vulnerabilities to drugs that spur the natural
cell - death
process.
The study also suggests that targeting the machinery that makes
cells mobile, rather than targeting the tissue - clearing
process — which has been tested in patients but has not been very effective — may be a better treatment strategy to stop
cancers from spreading.
If these
processes are defective,
cells acquire the wrong identity — which can ultimately lead to
cancer.
They chose drugs that cut off the
cancer's ability to burn glucose and shut down protective
processes that help
cancer cells survive.
Tumours grow through a
process of Darwinian evolution, where
cancer cells develop an advantageous mutation that allows them to survive and multiply, producing a population of
cells which can mutate further.
«With this discovery in our hands, we'd now like to try to find out which additional immune -
cell properties
cancer cells have and study how they affect the metastatic
process,» says Dr Fuxe.
«The knowledge we have gained may be applicable for future intervention of this
process to block the replication of viral pathogens and
cancer cells.»
This
process often goes wrong in
cancer cells, resulting in chromosomal instability.
PARP inhibitors also cause PARP to become trapped in the
cancer cells» DNA, a
process that is greatly enhanced when a DMNT inhibitor is added, Dr. Rassool says.
«The protein PITPNC1 regulates a
process whereby the
cancer cells are secreting molecules, which cut through a network of proteins outside the
cells, like scissors.
The team also showed that the cellular
process macropinocytosis, which participates in
cell scavenging nutrients and vesicles, contributes to exosomes uptake in
cancer cells with mutant KRAS.
The researchers observed the effect of the synthetically produced molecule, JK - 31, on the growth and proliferation of a model human breast
cancer cell line and found that it effectively blocked the protein cyclin - dependent kinase 1 (CDK1), which plays a key part in the
process of the division of
cancer cells, and therefore inhibited the proliferation of the
cells.
The biopsy removes fluid from the cysts, which is then analyzed for
cancer cells and other telltale signs of the disease, a
process called cytology.
Although this is a normal
process in embryogenesis to build new tissues, when it occurs in
cancer cells it generates metastasis.
A team from the Spanish National
Cancer Research Centre (CNIO) has determined for the first time the high - resolution structure of a complex (R2TP) involved in key processes for cell survival and in diseases such as c
Cancer Research Centre (CNIO) has determined for the first time the high - resolution structure of a complex (R2TP) involved in key
processes for
cell survival and in diseases such as
cancercancer.
In a
process called cellular reprogramming, researchers at Icahn School of Medicine at Mount Sinai have taken mature blood
cells from patients with myelodysplastic syndrome (MDS) and reprogrammed them back into iPSCs to study the genetic origins of this rare blood
cancer.
Cancer cell illustration courtesy of iStockphoto / Eraxion Chemotherapy treatment for cancer is a nasty pr
Cancer cell illustration courtesy of iStockphoto / Eraxion Chemotherapy treatment for
cancer is a nasty pr
cancer is a nasty
process.
Óscar Llorca and his team have used this technique to learn about the structure and functioning of a complex system called R2TP, which is involved in various key
processes for
cell survival such as the activation of the kinases mTOR, ATR and ATM, proteins that are the target of various
cancer drugs currently being developed.
Autophagy is a
process by which
cancer cells recycle essential building blocks to fuel further growth.
Center for Nuclear Receptors &
Cell Signaling (CNRCS) Assistant Professor Daniel Frigo and his research team recently published a study investigating the
processes through which androgen receptors affect prostate
cancer progression.
The new research, which studied the immortalization
process using genome - engineered
cells in culture and also tracked skin
cells as they progressed from a mole into a malignant melanoma, suggests that telomerase plays a more complex role in
cancer.
The
cancer cells, she explains, seem to hijack metabolic
processes so they — not the healthy
cells — get the energy they need to thrive.
«Two - step
process leads to
cell immortalization and
cancer: Clearer view of the role telomere length and telomerase play in
cell immortalization.»
To see whether
cancer stem
cell renewal involves a chain of events similar to that used by embryonic stem
cells, and whether the
process was affected by oxygen levels, Semenza and graduate student Chuanzhao Zhang focused their studies on two human breast
cancer cell lines that responded to low oxygen by ramping up production of the protein ALKBH5, which removes methyl groups from mRNAs.
The IFNGR receptor is one of these membrane proteins and undertakes to activate genes involved in a huge variety of
cell processes, including defence against pathogens and
cancer.
Moffitt
Cancer Center researchers have found that a protein called TBK1 plays an important role in the
process of
cell division, especially at a stage called mitosis.
Based on the pioneering work of Dr. Claire Lugassy and Dr. Raymond Barnhill at UCLA's Jonsson Comprehensive
Cancer Center, a new study provides additional support for a process by which melanoma cells, a deadly form of skin cancer, can spread throughout the body by creeping like tiny spiders along the outside of blood vessels without ever entering the blood stream, and that this process is exacerbated by exposure to ultraviolet (UV)
Cancer Center, a new study provides additional support for a
process by which melanoma
cells, a deadly form of skin
cancer, can spread throughout the body by creeping like tiny spiders along the outside of blood vessels without ever entering the blood stream, and that this process is exacerbated by exposure to ultraviolet (UV)
cancer, can spread throughout the body by creeping like tiny spiders along the outside of blood vessels without ever entering the blood stream, and that this
process is exacerbated by exposure to ultraviolet (UV) light.
«But mounting evidence confirming angiotropism and EVMM has revolutionized the knowledge of how
cancer spreads through the body to the point that other scientists have confirmed the
process in other solid tumor
cell types such as pancreatic
cancer.»
Healthy
cells without
cancer markers would remain unaffected by this
process.
Autophagy — an essential
process cancer cells need to fuel their growth — is a key troublemaker spurring tumor growth.
In a bid to progress beyond the shotgun approach to fighting
cancer — blasting malignant
cells with toxic chemicals or radiation, which kills surrounding healthy
cells in the
process — researchers at the Harvard - MIT Division of Health Sciences and Technology (HST) are using nanotechnology to develop seek - and - destroy models to zero in on and dismantle tumors without damaging nearby normal tissue.